Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, has won the OpenADMET-ExpansionRx blind challenge with its Beacon models, placing first among more than 370 submissions ...

Researchers from The Ohio State University and the Indian Institute of Technology Madras have developed an artificial intelligence framework to rapidly generate drug-like molecules that are easier to ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

AI has fundamentally altered the feasibility of natural product discovery from fungal endophytes. Advances in genome ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...

LG AI Research said Tuesday it has registered a patent for Exaone Discovery, a generative AI platform designed to speed up ...

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional ...

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

This pharmaceutical giant is increasingly looking unstoppable.

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...